Loading...
Market
Will Ozempic be FDA approved for Alzheimer's by June 2025?
4
Resolution / Starting Odds
Yes • 50%
No • 50%
Official FDA announcements or press releases
Story
Ozempic Shows Promise in Reducing Advanced Alzheimer's Risk, Potential 70% Reduction in Dementia by 2025
Dec 26, 2024, 08:53 AM
Recent studies are exploring the potential of Ozempic, a weight-loss medication, to aid in the fight against advanced Alzheimer's disease. Scientists are investigating its anti-inflammatory properties, which may contribute to a significant reduction in the risk of developing dementia. Early findings indicate that patients receiving the medication could see up to a 70% reduced risk of dementia. However, further research is needed, with more comprehensive results expected in 2025.
View original story
Similar markets
No • 50%
Yes • 50%
Conditional Approval • 25%
Withdrawn by Axsome • 25%
Approved • 25%
Rejected • 25%
Diabetic Macular Edema • 25%
Metabolic Liver Dysfunction • 25%
Addiction Treatment • 25%
Other • 25%
Yes • 50%
No • 50%